{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T09:36:25Z","timestamp":1776332185829,"version":"3.50.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001474","name":"Singapore-MIT Alliance for Research and Technology Centre","doi-asserted-by":"publisher","award":["M4062347.080"],"award-info":[{"award-number":["M4062347.080"]}],"id":[{"id":"10.13039\/501100001474","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001474","name":"Singapore-MIT Alliance for Research and Technology Centre","doi-asserted-by":"publisher","award":["M4062198.080"],"award-info":[{"award-number":["M4062198.080"]}],"id":[{"id":"10.13039\/501100001474","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","award":["NRF-CRP21-2018-0002"],"award-info":[{"award-number":["NRF-CRP21-2018-0002"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The precise, functional and safe insertion of large DNA payloads into host genomes offers versatility in downstream genetic engineering-associated applications, spanning cell and gene therapies, therapeutic protein production, high-throughput cell-based drug screening and reporter cell lines amongst others. Employing viral- and non-viral-based genome engineering tools to achieve specific insertion of large DNA\u2014despite being successful in <jats:italic>E. coli<\/jats:italic> and animal models\u2014still pose challenges in the human system. In this study, we demonstrate the applicability of our lambda integrase-based genome insertion tool for human cell and gene therapy applications that require insertions of large functional genes, as exemplified by the integration of a functional copy of the <jats:italic>F8<\/jats:italic> gene and a Double Homeobox Protein 4 (DUX4)-based reporter cassette for potential hemophilia A gene therapy and facioscapulohumeral muscular dystrophy (FSHD)-based high-throughput drug screening purposes, respectively. Thus, we present a non-viral genome insertion tool for safe and functional delivery of large seamless DNA cargo into the human genome that can enable novel designer cell-based therapies.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Previously, we have demonstrated the utility of our phage \u03bb-integrase platform to generate seamless vectors and subsequently achieve functional integration of large-sized DNA payloads at defined loci in the human genome. To further explore this tool for therapeutic applications, we used pluripotent human embryonic stem cells (hESCs) to integrate large seamless vectors comprising a \u2018gene of interest\u2019. Clonal cell populations were screened for the correct integration events and further characterized by southern blotting, gene expression and protein activity assays. In the case of our hemophilia A-related study, clones were differentiated to confirm that the targeted locus is active after differentiation and actively express and secrete Factor VIII.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The two independent approaches demonstrated specific and functional insertions of a full-length blood clotting F8 expression cassette of ~\u200910\u2009kb and of a DUX4 reporter cassette of ~\u20097\u2009kb in hESCs.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>We present a versatile tool for site-specific human genome engineering with large transgenes for cell\/gene therapies and other synthetic biology and biomedical applications.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13287-020-01890-6","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T08:03:43Z","timestamp":1599120223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A non-viral genome editing platform for site-specific insertion of large transgenes"],"prefix":"10.1186","volume":"11","author":[{"given":"Namrata","family":"Chaudhari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda M.","family":"Rickard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suki","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Dr\u00f6ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshyaa","family":"Makhija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"1890_CR1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev-bioeng-071811-150118","volume":"14","author":"AA Cheng","year":"2012","unstructured":"Cheng AA, Lu TK. Synthetic biology: an emerging engineering discipline. Annu Rev Biomed Eng. 2012;14:155\u201378.","journal-title":"Annu Rev Biomed Eng"},{"issue":"4","key":"1890_CR2","first-page":"442","volume":"11","author":"DR Deyle","year":"2009","unstructured":"Deyle DR, Russell DW. Adeno-associated virus vector integration. Curr Opin Mol Ther. 2009;11(4):442\u20137.","journal-title":"Curr Opin Mol Ther"},{"issue":"13","key":"1890_CR3","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1182\/blood-2011-09-382317","volume":"119","author":"G Buchlis","year":"2012","unstructured":"Buchlis G, Podsakoff GM, Radu A, Hawk SM, Flake AW, Mingozzi F, et al. Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer. Blood. 2012;119(13):3038\u201341.","journal-title":"Blood."},{"issue":"1","key":"1890_CR4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/mt.2009.256","volume":"18","author":"Y Lai","year":"2010","unstructured":"Lai Y, Yue Y, Duan D. Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or = 8.2 kb. Mol Ther. 2010;18(1):75\u20139.","journal-title":"Mol Ther"},{"key":"1890_CR5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/02648725.2007.10648098","volume":"24","author":"A Ghosh","year":"2007","unstructured":"Ghosh A, Duan D. Expanding adeno-associated viral vector capacity: a tale of two vectors. Biotechnol Genet Eng Rev. 2007;24:165\u201377.","journal-title":"Biotechnol Genet Eng Rev"},{"issue":"1","key":"1890_CR6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/sj.mt.6300322","volume":"16","author":"A Ghosh","year":"2008","unstructured":"Ghosh A, Yue Y, Lai Y, Duan D. A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner. Mol Ther. 2008;16(1):124\u201330.","journal-title":"Mol Ther"},{"issue":"15","key":"1890_CR7","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1089\/104303401753153947","volume":"12","author":"M Kumar","year":"2001","unstructured":"Kumar M, Keller B, Makalou N, Sutton RE. Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther. 2001;12(15):1893\u2013905.","journal-title":"Hum Gene Ther"},{"issue":"3","key":"1890_CR8","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1093\/nar\/gku1246","volume":"43","author":"SM Byrne","year":"2015","unstructured":"Byrne SM, Ortiz L, Mali P, Aach J, Church GM. Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells. Nucleic Acids Res. 2015;43(3):e21.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1890_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/hgtb.2015.140","volume":"27","author":"K Chamberlain","year":"2016","unstructured":"Chamberlain K, Riyad JM, Weber T. Expressing transgenes that exceed the packaging capacity of adeno-associated virus capsids. Hum Gene Ther Methods. 2016;27(1):1\u201312.","journal-title":"Hum Gene Ther Methods"},{"issue":"7","key":"1890_CR10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jgm.1052","volume":"9","author":"N al Yacoub","year":"2007","unstructured":"al Yacoub N, Romanowska M, Haritonova N, Foerster J. Optimized production and concentration of lentiviral vectors containing large inserts. J Gene Med. 2007;9(7):579\u201384.","journal-title":"J Gene Med"},{"issue":"7","key":"1890_CR11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41587-020-0565-5","volume":"38","author":"J van Haasteren","year":"2020","unstructured":"van Haasteren J, Li J, Scheideler OJ, Murthy N, Schaffer DV. The delivery challenge: fulfilling the promise of therapeutic genome editing. Nat Biotechnol. 2020;38(7):845\u201355.","journal-title":"Nat Biotechnol"},{"issue":"8","key":"1890_CR12","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1182\/blood-2005-08-024976","volume":"108","author":"U Modlich","year":"2006","unstructured":"Modlich U, Bohne J, Schmidt M, von Kalle C, Knoss S, Schambach A, et al. Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood. 2006;108(8):2545\u201353.","journal-title":"Blood."},{"issue":"6","key":"1890_CR13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nbt1216","volume":"24","author":"E Montini","year":"2006","unstructured":"Montini E, Cesana D, Schmidt M, Sanvito F, Ponzoni M, Bartholomae C, et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol. 2006;24(6):687\u201396.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"1890_CR14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/gt.2009.148","volume":"17","author":"S Nayak","year":"2010","unstructured":"Nayak S, Herzog RW. Progress and prospects: immune responses to viral vectors. Gene Ther. 2010;17(3):295\u2013304.","journal-title":"Gene Ther"},{"issue":"R1","key":"1890_CR15","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1093\/hmg\/ddv451","volume":"25","author":"JC van der Loo","year":"2016","unstructured":"van der Loo JC, Wright JF. Progress and challenges in viral vector manufacturing. Hum Mol Genet. 2016;25(R1):R42\u201352.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"1890_CR16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","volume":"38","author":"AV Anzalone","year":"2020","unstructured":"Anzalone AV, Koblan LW, Liu DR. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol. 2020;38(7):824\u201344.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"1890_CR17","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/biot.201400046","volume":"9","author":"E Senis","year":"2014","unstructured":"Senis E, Fatouros C, Grosse S, Wiedtke E, Niopek D, Mueller AK, et al. CRISPR\/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox. Biotechnol J. 2014;9(11):1402\u201312.","journal-title":"Biotechnol J"},{"issue":"8","key":"1890_CR18","doi-asserted-by":"crossref","first-page":"e105779","DOI":"10.1371\/journal.pone.0105779","volume":"9","author":"K Li","year":"2014","unstructured":"Li K, Wang G, Andersen T, Zhou P, Pu WT. Optimization of genome engineering approaches with the CRISPR\/Cas9 system. PLoS One. 2014;9(8):e105779.","journal-title":"PLoS One"},{"key":"1890_CR19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/B978-0-12-801185-0.00003-9","volume":"546","author":"V Pattanayak","year":"2014","unstructured":"Pattanayak V, Guilinger JP, Liu DR. Determining the specificities of TALENs, Cas9, and other genome-editing enzymes. Methods Enzymol. 2014;546:47\u201378.","journal-title":"Methods Enzymol"},{"issue":"9","key":"1890_CR20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","volume":"31","author":"Y Fu","year":"2013","unstructured":"Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol. 2013;31(9):822\u20136.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"1890_CR21","first-page":"943","volume":"41","author":"SH Lee","year":"2018","unstructured":"Lee SH, Kim S, Hur JK. CRISPR and target-specific DNA endonucleases for efficient DNA knock-in in eukaryotic genomes. Mol Cells. 2018;41(11):943\u201352.","journal-title":"Mol Cells"},{"issue":"15","key":"1890_CR22","doi-asserted-by":"crossref","first-page":"8403","DOI":"10.1073\/pnas.111009698","volume":"98","author":"KM Vasquez","year":"2001","unstructured":"Vasquez KM, Marburger K, Intody Z, Wilson JH. Manipulating the mammalian genome by homologous recombination. Proc Natl Acad Sci U S A. 2001;98(15):8403\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1890_CR23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/138920210790886871","volume":"11","author":"M Munoz-Lopez","year":"2010","unstructured":"Munoz-Lopez M, Garcia-Perez JL. DNA transposons: nature and applications in genomics. Curr Genomics. 2010;11(2):115\u201328.","journal-title":"Curr Genomics"},{"issue":"6448","key":"1890_CR24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1126\/science.aax9181","volume":"365","author":"J Strecker","year":"2019","unstructured":"Strecker J, Ladha A, Gardner Z, Schmid-Burgk JL, Makarova KS, Koonin EV, et al. RNA-guided DNA insertion with CRISPR-associated transposases. Science. 2019;365(6448):48\u201353.","journal-title":"Science."},{"issue":"35","key":"1890_CR25","doi-asserted-by":"crossref","first-page":"E7358","DOI":"10.1073\/pnas.1709035114","volume":"114","author":"JE Peters","year":"2017","unstructured":"Peters JE, Makarova KS, Shmakov S, Koonin EV. Recruitment of CRISPR-Cas systems by Tn7-like transposons. Proc Natl Acad Sci U S A. 2017;114(35):E7358\u2013E66.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1890_CR26","doi-asserted-by":"crossref","first-page":"ysz018","DOI":"10.1093\/synbio\/ysz018","volume":"4","author":"BE Hew","year":"2019","unstructured":"Hew BE, Sato R, Mauro D, Stoytchev I, Owens JB. RNA-guided piggyBac transposition in human cells. Synth Biol (Oxf). 2019;4(1):ysz018.","journal-title":"Synth Biol (Oxf)"},{"issue":"7631","key":"1890_CR27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","volume":"540","author":"K Suzuki","year":"2016","unstructured":"Suzuki K, Tsunekawa Y, Hernandez-Benitez R, Wu J, Zhu J, Kim EJ, et al. In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration. Nature. 2016;540(7631):144\u20139.","journal-title":"Nature."},{"issue":"3","key":"1890_CR28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1101\/gr.145441.112","volume":"23","author":"M Maresca","year":"2013","unstructured":"Maresca M, Lin VG, Guo N, Yang Y. Obligate ligation-gated recombination (ObLiGaRe): custom-designed nuclease-mediated targeted integration through nonhomologous end joining. Genome Res. 2013;23(3):539\u201346.","journal-title":"Genome Res"},{"issue":"1","key":"1890_CR29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nprot.2015.140","volume":"11","author":"T Sakuma","year":"2016","unstructured":"Sakuma T, Nakade S, Sakane Y, Suzuki KT, Yamamoto T. MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems. Nat Protoc. 2016;11(1):118\u201333.","journal-title":"Nat Protoc"},{"key":"1890_CR30","doi-asserted-by":"crossref","first-page":"10431","DOI":"10.1038\/ncomms10431","volume":"7","author":"K Yoshimi","year":"2016","unstructured":"Yoshimi K, Kunihiro Y, Kaneko T, Nagahora H, Voigt B, Mashimo T. ssODN-mediated knock-in with CRISPR-Cas for large genomic regions in zygotes. Nat Commun. 2016;7:10431.","journal-title":"Nat Commun"},{"key":"1890_CR31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-4939-2727-2_18","volume":"1317","author":"M Schleef","year":"2015","unstructured":"Schleef M, Schirmbeck R, Reiser M, Michel ML, Schmeer M. Minicircle: next generation DNA vectors for vaccination. Methods Mol Biol. 2015;1317:327\u201339.","journal-title":"Methods Mol Biol"},{"issue":"6","key":"1890_CR32","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0264-410X(00)00249-8","volume":"19","author":"AM Krieg","year":"2000","unstructured":"Krieg AM. Immune effects and mechanisms of action of CpG motifs. Vaccine. 2000;19(6):618\u201322.","journal-title":"Vaccine."},{"issue":"3","key":"1890_CR33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1525-0016(03)00168-0","volume":"8","author":"ZY Chen","year":"2003","unstructured":"Chen ZY, He CY, Ehrhardt A, Kay MA. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther. 2003;8(3):495\u2013500.","journal-title":"Mol Ther"},{"issue":"1","key":"1890_CR34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.smim.2003.10.009","volume":"16","author":"F Takeshita","year":"2004","unstructured":"Takeshita F, Gursel I, Ishii KJ, Suzuki K, Gursel M, Klinman DM. Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9. Semin Immunol. 2004;16(1):17\u201322.","journal-title":"Semin Immunol"},{"issue":"5","key":"1890_CR35","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.4161\/hv.28077","volume":"10","author":"S Stenler","year":"2014","unstructured":"Stenler S, Blomberg P, Smith CI. Safety and efficacy of DNA vaccines: plasmids vs. minicircles. Hum Vaccin Immunother. 2014;10(5):1306\u20138.","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"1890_CR36","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nrg2971","volume":"12","author":"MA Kay","year":"2011","unstructured":"Kay MA. State-of-the-art gene-based therapies: the road ahead. Nat Rev Genet. 2011;12(5):316\u201328.","journal-title":"Nat Rev Genet"},{"key":"1890_CR37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biomaterials.2016.03.029","volume":"93","author":"RP Bazzani","year":"2016","unstructured":"Bazzani RP, Pringle IA, Connolly MM, Davies LA, Sumner-Jones SG, Schleef M, et al. Transgene sequences free of CG dinucleotides lead to high level, long-term expression in the lung independent of plasmid backbone design. Biomaterials. 2016;93:20\u20136.","journal-title":"Biomaterials."},{"issue":"11","key":"1890_CR38","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/jgm.1243","volume":"10","author":"P Mayrhofer","year":"2008","unstructured":"Mayrhofer P, Blaesen M, Schleef M, Jechlinger W. Minicircle-DNA production by site specific recombination and protein-DNA interaction chromatography. J Gene Med. 2008;10(11):1253\u201369.","journal-title":"J Gene Med."},{"issue":"4","key":"1890_CR39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000086703","volume":"8","author":"W Jechlinger","year":"2004","unstructured":"Jechlinger W, Azimpour Tabrizi C, Lubitz W, Mayrhofer P. Minicircle DNA immobilized in bacterial ghosts: in vivo production of safe non-viral DNA delivery vehicles. J Mol Microbiol Biotechnol. 2004;8(4):222\u201331.","journal-title":"J Mol Microbiol Biotechnol"},{"key":"1890_CR40","first-page":"325","volume":"2017","author":"NS Ata-Abadi","year":"1642","unstructured":"Ata-Abadi NS, Rezaei N, Dormiani K, Nasr-Esfahani MH. Production of minicircle DNA vectors using site-specific recombinases. Methods Mol Biol. 1642;2017:325\u201339.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"1890_CR41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.gt.3300816","volume":"6","author":"AM Darquet","year":"1999","unstructured":"Darquet AM, Rangara R, Kreiss P, Schwartz B, Naimi S, Delaere P, et al. Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer. Gene Ther. 1999;6(2):209\u201318.","journal-title":"Gene Ther"},{"issue":"12","key":"1890_CR42","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nbt.1708","volume":"28","author":"MA Kay","year":"2010","unstructured":"Kay MA, He CY, Chen ZY. A robust system for production of minicircle DNA vectors. Nat Biotechnol. 2010;28(12):1287\u20139.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"1890_CR43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/protein\/gzv015","volume":"28","author":"JW Siau","year":"2015","unstructured":"Siau JW, Chee S, Makhija H, Wai CM, Chandra SH, Peter S, et al. Directed evolution of lambda integrase activity and specificity by genetic derepression. Protein Eng Des Sel. 2015;28(7):211\u201320.","journal-title":"Protein Eng Des Sel"},{"issue":"6","key":"1890_CR44","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1093\/nar\/gkv1345","volume":"44","author":"SH Vijaya Chandra","year":"2016","unstructured":"Vijaya Chandra SH, Makhija H, Peter S, Myint Wai CM, Li J, Zhu J, et al. Conservative site-specific and single-copy transgenesis in human LINE-1 elements. Nucleic Acids Res. 2016;44(6):e55.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"1890_CR45","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1093\/nar\/gky500","volume":"46","author":"H Makhija","year":"2018","unstructured":"Makhija H, Roy S, Hoon S, Ghadessy FJ, Wong D, Jaiswal R, et al. A novel lambda integrase-mediated seamless vector transgenesis platform for therapeutic protein expression. Nucleic Acids Res. 2018;46(16):e99.","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"1890_CR46","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1093\/nar\/gkg711","volume":"31","author":"T Corona","year":"2003","unstructured":"Corona T, Bao Q, Christ N, Schwartz T, Li J, Droge P. Activation of site-specific DNA integration in human cells by a single chain integration host factor. Nucleic Acids Res. 2003;31(17):5140\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1890_CR47","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1006\/jmbi.2000.3532","volume":"296","author":"E Lorbach","year":"2000","unstructured":"Lorbach E, Christ N, Schwikardi M, Droge P. Site-specific recombination in human cells catalyzed by phage lambda integrase mutants. J Mol Biol. 2000;296(5):1175\u201381.","journal-title":"J Mol Biol"},{"issue":"6","key":"1890_CR48","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101\u20138.","journal-title":"Nat Protoc"},{"issue":"1\u20132","key":"1890_CR49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1\u20132):55\u201363.","journal-title":"J Immunol Methods"},{"issue":"1","key":"1890_CR50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/mt.2012.244","volume":"21","author":"LE Gracey Maniar","year":"2013","unstructured":"Gracey Maniar LE, Maniar JM, Chen ZY, Lu J, Fire AZ, Kay MA. Minicircle DNA vectors achieve sustained expression reflected by active chromatin and transcriptional level. Mol Ther. 2013;21(1):131\u20138.","journal-title":"Mol Ther"},{"issue":"3","key":"1890_CR51","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/mt.2010.249","volume":"19","author":"MJ Osborn","year":"2011","unstructured":"Osborn MJ, McElmurry RT, Lees CJ, DeFeo AP, Chen ZY, Kay MA, et al. Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of alpha-L-iduronidase in mice with mucopolysaccharidosis type I. Mol Ther. 2011;19(3):450\u201360.","journal-title":"Mol Ther"},{"issue":"10","key":"1890_CR52","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/sj.gt.3302231","volume":"11","author":"ZY Chen","year":"2004","unstructured":"Chen ZY, He CY, Meuse L, Kay MA. Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo. Gene Ther. 2004;11(10):856\u201364.","journal-title":"Gene Ther"},{"issue":"2","key":"1890_CR53","first-page":"309","volume":"12","author":"P Savatier","year":"1996","unstructured":"Savatier P, Lapillonne H, van Grunsven LA, Rudkin BB, Samarut J. Withdrawal of differentiation inhibitory activity\/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Oncogene. 1996;12(2):309\u201322.","journal-title":"Oncogene."},{"issue":"1","key":"1890_CR54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/ng0992-26","volume":"2","author":"C Wijmenga","year":"1992","unstructured":"Wijmenga C, Hewitt JE, Sandkuijl LA, Clark LN, Wright TJ, Dauwerse HG, et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet. 1992;2(1):26\u201330.","journal-title":"Nat Genet"},{"issue":"7","key":"1890_CR55","doi-asserted-by":"crossref","first-page":"e1000559","DOI":"10.1371\/journal.pgen.1000559","volume":"5","author":"W Zeng","year":"2009","unstructured":"Zeng W, de Greef JC, Chen YY, Chien R, Kong X, Gregson HC, et al. Specific loss of histone H3 lysine 9 trimethylation and HP1gamma\/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). PLoS Genet. 2009;5(7):e1000559.","journal-title":"PLoS Genet"},{"issue":"3","key":"1890_CR56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ncl.2014.04.003","volume":"32","author":"J Statland","year":"2014","unstructured":"Statland J, Tawil R. Facioscapulohumeral muscular dystrophy. Neurol Clin. 2014;32(3):721\u20138 ix.","journal-title":"Neurol Clin"},{"issue":"1","key":"1890_CR57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ajh.1146","volume":"68","author":"R Nuss","year":"2001","unstructured":"Nuss R, Soucie JM, Evatt B. Hemophilia Surveillance System Project I. Changes in the occurrence of and risk factors for hemophilia-associated intracranial hemorrhage. Am J Hematol. 2001;68(1):37\u201342.","journal-title":"Am J Hematol"},{"issue":"7","key":"1890_CR58","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1182\/blood-2003-03-0941","volume":"102","author":"A Gringeri","year":"2003","unstructured":"Gringeri A, Mantovani LG, Scalone L, Mannucci PM, Group CS. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group. Blood. 2003;102(7):2358\u201363.","journal-title":"Blood."},{"issue":"3\u20134","key":"1890_CR59","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000090931","volume":"115","author":"G Young","year":"2006","unstructured":"Young G. New approaches in the management of inhibitor patients. Acta Haematol. 2006;115(3\u20134):172\u20139.","journal-title":"Acta Haematol"},{"issue":"6","key":"1890_CR60","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","volume":"357","author":"MJ Manco-Johnson","year":"2007","unstructured":"Manco-Johnson MJ, Abshire TC, Shapiro AD, Riske B, Hacker MR, Kilcoyne R, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535\u201344.","journal-title":"N Engl J Med"},{"issue":"2","key":"1890_CR61","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1538-7836.2009.03703.x","volume":"8","author":"PW Collins","year":"2010","unstructured":"Collins PW, Bjorkman S, Fischer K, Blanchette V, Oh M, Schroth P, et al. Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens. J Thromb Haemost. 2010;8(2):269\u201375.","journal-title":"J Thromb Haemost"},{"key":"1890_CR62","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2147\/JBM.S6885","volume":"1","author":"A Coppola","year":"2010","unstructured":"Coppola A, Di Capua M, Di Minno MN, Di Palo M, Marrone E, Ierano P, et al. Treatment of hemophilia: a review of current advances and ongoing issues. J Blood Med. 2010;1:183\u201395.","journal-title":"J Blood Med"},{"issue":"24","key":"1890_CR63","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1182\/blood-2015-10-675140","volume":"127","author":"MA Mazepa","year":"2016","unstructured":"Mazepa MA, Monahan PE, Baker JR, Riske BK, Soucie JM, Network USHTC. Men with severe hemophilia in the United States: birth cohort analysis of a large national database. Blood. 2016;127(24):3073\u201381.","journal-title":"Blood."},{"issue":"9","key":"1890_CR64","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/2040620718791933","volume":"9","author":"BS Doshi","year":"2018","unstructured":"Doshi BS, Arruda VR. Gene therapy for hemophilia: what does the future hold? Ther Adv Hematol. 2018;9(9):273\u201393.","journal-title":"Ther Adv Hematol"},{"key":"1890_CR65","first-page":"288","volume":"24","author":"J Gitschier","year":"1992","unstructured":"Gitschier J, Wood WI, Goralka TM, Wion KL, Chen EY, Eaton DH, et al. Characterization of the human factor VIII gene. 1984. Biotechnology. 1992;24:288\u201392.","journal-title":"Biotechnology."},{"issue":"17","key":"1890_CR66","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1182\/blood-2012-10-462200","volume":"121","author":"J McIntosh","year":"2013","unstructured":"McIntosh J, Lenting PJ, Rosales C, Lee D, Rabbanian S, Raj D, et al. Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant. Blood. 2013;121(17):3335\u201344.","journal-title":"Blood."},{"issue":"9","key":"1890_CR67","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1517\/21678707.2015.1069179","volume":"3","author":"VR Arruda","year":"2015","unstructured":"Arruda VR, Samelson-Jones BJ. Obstacles and future of gene therapy for hemophilia. Expert Opin Orphan Drugs. 2015;3(9):997\u20131010.","journal-title":"Expert Opin Orphan Drugs"},{"issue":"26","key":"1890_CR68","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1708483","volume":"377","author":"S Rangarajan","year":"2017","unstructured":"Rangarajan S, Walsh L, Lester W, Perry D, Madan B, Laffan M, et al. AAV5-factor VIII gene transfer in severe hemophilia a. N Engl J Med. 2017;377(26):2519\u201330.","journal-title":"N Engl J Med"},{"key":"1890_CR69","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1182\/blood-2019-126007","volume":"134","author":"G Nguyen","year":"2019","unstructured":"Nguyen G, Everett J, Raymond H, Kafle S, Merricks E, Kazazian H, et al. Long-term AAV-mediated Factor VIII expression in nine hemophilia A dogs: a 10 year follow-up analysis on durability, safety and vector integration. Blood. 2019;134:611.","journal-title":"Blood"},{"key":"1890_CR70","doi-asserted-by":"crossref","unstructured":"Kaiser J. Virus used in gene therapies may pose cancer risk, dog study hints. Science. 2020.","DOI":"10.1126\/science.aba7696"},{"issue":"2","key":"1890_CR71","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.stem.2015.07.001","volume":"17","author":"CY Park","year":"2015","unstructured":"Park CY, Kim DH, Son JS, Sung JJ, Lee J, Bae S, et al. Functional correction of large factor VIII gene chromosomal inversions in hemophilia a patient-derived iPSCs using CRISPR-Cas9. Cell Stem Cell. 2015;17(2):213\u201320.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"1890_CR72","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bbrc.2016.02.083","volume":"472","author":"J Pang","year":"2016","unstructured":"Pang J, Wu Y, Li Z, Hu Z, Wang X, Hu X, et al. Targeting of the human F8 at the multicopy rDNA locus in hemophilia A patient-derived iPSCs using TALENickases. Biochem Biophys Res Commun. 2016;472(1):144\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"1890_CR73","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/j.1538-7836.2008.03022.x","volume":"6","author":"S Kasuda","year":"2008","unstructured":"Kasuda S, Kubo A, Sakurai Y, Irion S, Ohashi K, Tatsumi K, et al. Establishment of embryonic stem cells secreting human factor VIII for cell-based treatment of hemophilia A. J Thromb Haemost. 2008;6(8):1352\u20139.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"1890_CR74","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.stemcr.2018.10.012","volume":"11","author":"C Olgasi","year":"2018","unstructured":"Olgasi C, Talmon M, Merlin S, Cucci A, Richaud-Patin Y, Ranaldo G, et al. Patient-specific iPSC-derived endothelial cells provide long-term phenotypic correction of hemophilia a. Stem Cell Reports. 2018;11(6):1391\u2013406.","journal-title":"Stem Cell Reports"},{"issue":"9","key":"1890_CR75","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1182\/bloodadvances.2017007914","volume":"3","author":"RB Lyde","year":"2019","unstructured":"Lyde RB, Ahn HS, Vo KK, Jarocha DJ, Tkaczynski J, Treffeisen E, et al. Infused factor VIII-expressing platelets or megakaryocytes as a novel therapeutic strategy for hemophilia A. Blood Adv. 2019;3(9):1368\u201378.","journal-title":"Blood Adv."},{"issue":"4","key":"1890_CR76","first-page":"45","volume":"51","author":"JJ Sung","year":"2019","unstructured":"Sung JJ, Park CY, Leem JW, Cho MS, Kim DW. Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCs. Exp Mol Med. 2019;51(4):45.","journal-title":"Exp Mol Med"},{"issue":"8","key":"1890_CR77","doi-asserted-by":"crossref","first-page":"e104957","DOI":"10.1371\/journal.pone.0104957","volume":"9","author":"H Matsui","year":"2014","unstructured":"Matsui H, Fujimoto N, Sasakawa N, Ohinata Y, Shima M, Yamanaka S, et al. Delivery of full-length factor VIII using a piggyBac transposon vector to correct a mouse model of hemophilia A. PLoS One. 2014;9(8):e104957.","journal-title":"PLoS One"},{"issue":"8","key":"1890_CR78","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/CJI.0b013e3181b2914c","volume":"32","author":"DL Galvan","year":"2009","unstructured":"Galvan DL, Nakazawa Y, Kaja A, Kettlun C, Cooper LJ, Rooney CM, et al. Genome-wide mapping of PiggyBac transposon integrations in primary human T cells. J Immunother. 2009;32(8):837\u201344.","journal-title":"J Immunother"},{"issue":"4","key":"1890_CR79","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1534\/genetics.112.140855","volume":"192","author":"K Furushima","year":"2012","unstructured":"Furushima K, Jang CW, Chen DW, Xiao N, Overbeek PA, Behringer RR. Insertional mutagenesis by a hybrid piggyBac and sleeping beauty transposon in the rat. Genetics. 2012;192(4):1235\u201348.","journal-title":"Genetics."},{"key":"1890_CR80","doi-asserted-by":"crossref","unstructured":"Hotra A, Ragunathan P, Ng PS, Seankongsuk P, Harikishore A, Sarathy JP, et al. Discovery of a Novel Mycobacterial F-ATP Synthase Inhibitor and its Potency in Combination with Diarylquinolines. Angew Chem Int Ed Engl. 2020;59(32):13295\u2013304.","DOI":"10.1002\/anie.202002546"},{"issue":"4","key":"1890_CR81","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/ng1262","volume":"35","author":"PG van Overveld","year":"2003","unstructured":"van Overveld PG, Lemmers RJ, Sandkuijl LA, Enthoven L, Winokur ST, Bakels F, et al. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet. 2003;35(4):315\u20137.","journal-title":"Nat Genet"},{"issue":"4","key":"1890_CR82","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.nurt.2008.07.005","volume":"5","author":"R Tawil","year":"2008","unstructured":"Tawil R. Facioscapulohumeral muscular dystrophy. Neurotherapeutics. 2008;5(4):601\u20136.","journal-title":"Neurotherapeutics."},{"issue":"1","key":"1890_CR83","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2012.01647.x","volume":"17","author":"A Tassin","year":"2013","unstructured":"Tassin A, Laoudj-Chenivesse D, Vanderplanck C, Barro M, Charron S, Ansseau E, et al. DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? J Cell Mol Med. 2013;17(1):76\u201389.","journal-title":"J Cell Mol Med"},{"issue":"20","key":"1890_CR84","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1093\/hmg\/ddv315","volume":"24","author":"AM Rickard","year":"2015","unstructured":"Rickard AM, Petek LM, Miller DG. Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways. Hum Mol Genet. 2015;24(20):5901\u201314.","journal-title":"Hum Mol Genet"},{"issue":"20","key":"1890_CR85","first-page":"4419","volume":"25","author":"S Jagannathan","year":"2016","unstructured":"Jagannathan S, Shadle SC, Resnick R, Snider L, Tawil RN, van der Maarel SM, et al. Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells. Hum Mol Genet. 2016;25(20):4419\u201331.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"1890_CR86","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.5966\/sctm.2015-0224","volume":"5","author":"L Caron","year":"2016","unstructured":"Caron L, Kher D, Lee KL, McKernan R, Dumevska B, Hidalgo A, et al. A human pluripotent stem cell model of facioscapulohumeral muscular dystrophy-affected skeletal muscles. Stem Cells Transl Med. 2016;5(9):1145\u201361.","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"1890_CR87","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.nmd.2016.12.007","volume":"27","author":"TI Jones","year":"2017","unstructured":"Jones TI, Himeda CL, Perez DP, Jones PL. Large family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy. Neuromuscul Disord. 2017;27(3):221\u201338.","journal-title":"Neuromuscul Disord"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01890-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-020-01890-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01890-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T08:44:19Z","timestamp":1630658659000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-01890-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1890"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-01890-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"15 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"H.M. and P.D. filed USA Patent Application No. 15\/629,334 entitled \u201cSite-Specific DNA Recombination\u201d related to the technology and are co-founders and shareholders of LambdaGen Pte. Ltd. N.C., A.M.R. and S.R. declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"380"}}